Altmetrics
Downloads
128
Views
45
Comments
0
This version is not peer-reviewed
Submitted:
20 September 2023
Posted:
22 September 2023
You are already at the latest version
Database | Medical Subject Headings |
---|---|
Pubmed/ Medline | (Ovary Syndrome, Polycystic OR Syndrome, Polycystic Ovary OR Stein-Leventhal Syndrome OR Sclerocystic Ovarian Degeneration OR Ovarian Degeneration, Sclerocystic OR Ovarian Degeneration, Sclerocystic OR Polycystic Ovary Syndrome OR Sclerocystic Ovary Syndrome OR Sclerocystic Ovaries) AND (Behavior, Sexual OR Sexual Activities OR Sexual Activity OR Sex Behavior OR Physiological Sexual Dysfunction OR Physiological Sexual Dysfunctions OR Sex Disorders OR Physiological Sexual Disorders) |
Embase | (Polycystic ovary syndrome OR polycystic ovary disease) AND (sexuality OR sexual behavior) |
Lilacs | [tw:(polycystic ovary syndrome)] AND [tw:(sexuality)] |
Cinahl | (Polycystic ovary syndrome AND Sexual Dysfunction) OR (Polycystic ovary syndrome AND Sexual Function) |
PsycINFO | Polycystic Ovary Syndrome AND (Behavior, Sexual OR Sexual Activities OR Sexual Activity OR Sex Behavior OR Physiological Sexual Dysfunction OR Physiological Sexual Dysfunctions OR Sex Disorders OR Physiological Sexual Disorders) |
Google Scholar | (Polycystic ovary syndrome AND Sexual Dysfunction) OR (Polycystic ovary syndrome AND Sexual Function) |
Cochrane | Polycystic Ovary Syndrome AND Sex Behavior |
Author/ Year/ Country | Study Design | Sample size per group (n) | Mean age ± SD | BMI ± SD | Total FSFI Comparison: PCOS Group vs. Control | Total FSFI p-value | Affected FSFI Domains |
---|---|---|---|---|---|---|---|
Benetti-Pinto et al 2014 Brazil [5] |
Case control | PCOS: 150 Control: 102 |
PCOS: 26.9 ± 4.9 Control: 35.6 ± 7.3 |
PCOS: 31.9 ± 8.5 Control: 28.5 ± 5.4 |
Lower in PCOS | p = 0.005 | Arousal, lubrication, satisfaction and pain |
Basirat et al 2019 Iran [25] |
Case control | PCOS: 120 Control: 120 |
PCOS: 29.55 ± 5.17 Control: 29.33 ± 6.23 |
PCOS: 39.5 ± 15.81 Control: 45.5 ± 5.48 |
Lower in PCOS | p < 0.05 | None |
Bahadori et al 2022 Iran [26] |
Cross sectional | PCOS: 192 Control: 50 |
PCOS: 31.17 ± 6.57 Control: 34.18 ± 4.13 |
PCOS: 26.71 ± 5.14 Control: 26.96 ± 3.12 |
Lower in PCOS | p < 0.05 | Arousal, lubrication and pain |
Mantzou et al 2021 Greece [27] |
Case control | PCOS: 76 Control: 133 |
PCOS: 22.17 ± 2.51 Control: 21.62 ± 1.93 |
PCOS: 23.97 ± 5.39 Control: 22.1 ± 4 |
Lower in PCOS | p < 0.001 | Arousal, lubrication, orgasm and satisfaction |
Ashrafi et al 2022 Iran [28] |
Cross sectional | PCOS: 80 Control: 160 |
PCOS: 31.94 ± 4.44 Control: 31.66 ± 1.89 |
PCOS: 27.04 ± 3.24 Control: 26.13 ± 3.75 |
Lower in PCOS | p < 0.001 | Desire, arousal, pain, lubrication, orgasm and satisfaction |
Deniz et al 2020 Turkey [29] |
Case control | PCOS: 50 Control: 50 |
PCOS: 32 ± 4 Control: 31 ± 4 |
PCOS: 25.1 ± 2.2 Control: 25.5 ± 2.3 |
Lower in PCOS | p = 0.001 | Desire, lubrication, orgasm, satisfaction and pain |
Tian et al 2023 Germania [10] |
Cross sectional | PCOS: 809 Control: 385 |
PCOS: 27.25 ± 3.98 Control: 27.56 ± 3.83 |
PCOS: 25.75 ± 3.95 Control: 23.35 ± 3.53 |
Lower in PCOS | p < 0.05 | Desire, orgasm, lubrication and satisfaction |
Mojahed et al 2023 Iran [30] |
Case control | PCOS: 106 Control: 106 |
PCOS: 26.9 ± 5.2 Control: 27.8 ± 6.8 |
N.A. | Lower in PCOS | p < 0.001 | Arousal, pain, lubrication, orgasm and satisfaction |
Hashemi et al 2014 Iran [31] |
Case control | PCOS: 128 Control: 407 |
PCOS: 30.6 ± 5.01 Control: 29.4 ± 5.8 |
PCOS: 26.7 ± 4.9 Control: 27.9 ± 6.1 |
Lower in PCOS | p < 0.05 | Satisfaction, orgasm, lubrication and arousal |
Anger et al 2007 USA [32] | Case control | PCOS: 33 | PCOS: 36 ± N.A. | N.A. | Lower in PCOS | p < 0.05 | Arousal and lubrication |
Eftekhar et al 2014 Iran [33] | Case control | PCOS: 130 | PCOS: 27.02 ± 4.27 | N.A. | Lower in PCOS | p < 0.05 | None |
Dashti et al 2016 Malasya[34] | Cross sectional | PCOS: 16 | PCOS: 33.44 ± 5.88 | PCOS: 28.04 ± 3.34 | Lower in PCOS | p < 0.05 | Arousal and lubrication |
Aba et al 2022 Turkey [35] |
Case control | PCOS: 97 Control: 95 |
PCOS: 28.23 ± 4.56 Control: 29.33 ± 5.61 |
PCOS: 25.08 ± 4.3 Control: 22.34 ± 3.74 |
Lower in PCOS | p < 0.05 | Desire, arousal, pain, lubrication and orgasm |
Daneshfar et al 2022 Iran [36] |
Cross sectional | PCOS: 210 Control: 210 |
PCOS: 30 ± 5.3 Control: 31.4 ± 2.7 |
PCOS: 26.6 ± 4.2 Control: 25.8 ± 3.7 |
Lower in PCOS | p < 0.001 | Desire, arousal, pain, lubrication, orgasm and satisfaction |
Taghavi et al 2021 Iran [37] |
Case control | PCOS: 90 Control: 90 |
PCOS: 28.8 ± 4.39 Control: 30 ± 4.83 |
PCOS: 24.99 ± 3.72 Control: 25.04 ± 3.38 |
Lower in PCOS | p < 0.05 | Desire, arousal, pain, lubrication, orgasm and satisfaction |
Kępczyńska-Nyk et al 2021 Poland [38] | Case control | PCOS: 60 Control: 23 |
PCOS: 26.56 ± 5.45 Control: 30.85 ± 6.73 |
PCOS: 27.58 ± 6.98 Control: 24.18 ± 4.37 |
Higher in PCOS | p > 0.05 | Satisfaction |
Ercan et al 2013 Turkey [39] |
Case control | PCOS: 32 Control: 32 |
PCOS: 27.4 ± 3.3 Control: 27 ± 3 |
PCOS: 24.4 ± 3.6 Control: 27 ± 3 |
PCOS similar to controls | p > 0.05 | None |
Ferraresi et al 2013 Brazil [40] |
Case control | PCOS: 48 Control: 45 |
PCOS: 26.1 ± 1.05 Control: 31.1 ± 1.02 |
PCOS: 34.2 ± 2.8 Control: 34.9 ± 3.2 |
Lower in PCOS | p > 0.05 | N.A. |
Lara et al 2015 Brazil [41] |
Case control | PCOS: 43 Control: 51 |
PCOS: 27.8 ± 5.34 Control: 29.74 ± 5.26 |
PCOS: 27.91 ± 5.51 Control: 25.99 ± 5.49 |
Lower in PCOS | p > 0.05 | Pain, lubrication and arousal |
Shafti et al 2016 Iran [42] |
Casual comparative study | PCOS: 129 Control: 125 |
PCOS: 30.10 ± N.A. Control: 32.79 ± N.A. |
N.A. | PCOS similar to controls | p > 0.05 | None |
Diamond et al 2017 Georgia [43] |
Cross sectional | PCOS: 734 Control: 860 |
PCOS: 95.1 ± 26.3 Control: 72.4 ± 18.5 |
PCOS: 35.2 ± 9.3 Control: 26.8 ± 6.4 |
PCOS similar to controls | p > 0.05 | Arousal and satisfaction |
Noroozzadeh et al 2017 Iran [44] |
Case control | PCOS: 63 Control: 216 |
PCOS: 33.6 ± 7.2 Control: 36.3 ± 6.9 |
PCOS: 27.14 ± 5.74 Control: 27.35 ± 4.95 |
Lower in PCOS | p > 0.05 | Orgasm and satisfaction |
Sene et al 2021 Iran [9] |
Case control | PCOS: 116 Control: 93 |
PCOS: 32 ± 5 Control: 34 ± 6 |
PCOS: 26.66 ± 3.85 Control: 26.58 ± 4.43 |
Lower in PCOS | p > 0.05 | Orgasm |
Altuntas et al 2022 Turkey [45] |
Cross sectional | PCOS: 167 Control: 73 |
PCOS: 25.87 ± 5.64 Control: 27.25 ± 5.85 |
PCOS: 29.32 ± 5.6 Control: 23.77 ± 4.22 |
Higher in PCOS | p > 0.05 | None |
Gateva et al 2012 Bulgaria [46] |
Case control | PCOS: 16 Control: 22 |
PCOS: 32.5 ± 8.5 Control: 32.5 ± 8.5 |
PCOS: 35.6 ± 4.9 Control: 40.2 ± 9.4 |
Lower in lean PCOS than obese PCOS |
p > 0.05 | Arousal, lubrication, orgasm, satisfaction and pain |
Kirmizi et al 2020 Turkey [47] |
Case control | PCOS: 50 Control: 30 |
PCOS: 25.1 ± 4.4 Control: 31.9 ± 4.73 |
PCOS: 26.4 ± 5.22 Control: 25.08 ± 4.84 |
Lower in PCOS | p > 0.05 | Lubrication |
Yıldız et al 2017 Turkey [48] |
Cross sectional | PCOS: 90 Control: 80 |
PCOS: 28.3 ± 2.12 Control: 29.1 ± 4.8 |
PCOS: 31.27 ± 7.1 Control: 23.9 ± 8.2 |
Lower in PCOS | p > 0.05 | Orgasm |
Naumova et al 2021 Spain [49] |
Case control | PCOS: 37 Control: 67 |
N.A. | N.A. | Lower in PCOS | p > 0.05 | Desire, arousal, lubrication, orgasm and satisfaction |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 MDPI (Basel, Switzerland) unless otherwise stated